T45.AX5A Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter

T45.AX5A is a new billable/specific diagnosis code introduced in the 2025 ICD-10-CM used to classify the following condition: Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter.